Back to BlackRock, Inc. BlackRock, Inc.

ANIPANIP
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ANI PHARMACEUTICALS INC

Yes. BlackRock holds 2,958,646 shares of ANIP (Ani Pharmaceuticals), worth $244.9M, as of its Q2 2026 13F filing. It increased the position by 211,154 shares (+7.7%) from Q1 2026. BlackRock has held ANIP in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$244.9M

Current Shares

3M

Total Value Change

+$84.4M

Total Shares Change

+268,934

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3M
+7.7%
$244.9M0.0%$82.78
33
2026-Q1
Increased
2.7M
+3.2%
$211.3M0.0%$76.90
32
2025-Q4
Increased
2.7M
+4.4%
$210.1M0.0%$78.94
32
2025-Q3
Decreased
2.5M
-1.2%
$233.5M0.0%$91.60
0
2025-Q2
Decreased
2.6M
-2.5%
$168.4M0.0%$65.25
0
2025-Q1
Decreased
2.6M
-3.4%
$177.2M0.0%$66.95
0
2024-Q4
Increased
2.7M
+1.8%
$151.4M0.0%$55.28
31
2024-Q3
First report
2.7M
-
$160.5M0.0%$59.66
0

Other major holders of ANIP: BlackRock Finance, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used